Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Cytokinetics

company

About

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$450M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 1998
Number Of Employee
251 - 500
Operating Status
Active
Stock Symbol
nasdaq:CYTK
Legal Name
Cytokinetics, Inc.

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
9
$1.23B
Cytokinetics has raised a total of $1.23B in funding over 2 rounds. Their latest funding was raised on Jul 1, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2022 Post-IPO Debt $450M 1 Royalty Pharma Detail
Jul 21, 2021 Post-IPO Equity $316.25M Detail
Jul 16, 2020 Post-IPO Equity $201.30M Detail
Feb 20, 2014 Post-IPO Equity $37.40M Detail
Jun 19, 2012 Post-IPO Equity $42.50M Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Cytokinetics has made 1 investments. Their most recent investment was on Nov 16, 2017, when zolar raised €4M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 16, 2017 zolar
Series A €4M Clean Energy

Investors

Number of Lead Investors
Number of Investors
3
5
Cytokinetics is funded by 5 investors. Royalty Pharma and Deepfield are the most recent investors.
Investor Name Lead Investor Funding Round
Royalty Pharma Yes Post-IPO Debt
Deepfield Yes Post-IPO Equity
Vulcan Yes Series E
Federated Kaufmann Fund Post-IPO Equity
Red Abbey Venture Partners Post-IPO Equity

Employee Profiles

Number of Employee Profiles
9
Cytokinetics has 9 current employee profiles, including Board member Steve Dow
Board member
Board member
Employee
Board member
Executive